We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+6.3%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$299M
AUM Growth
+$11.2M
Cap. Flow
-$2.11M
Cap. Flow %
-0.71%
Top 10 Hldgs %
36.39%
Holding
201
New
7
Increased
56
Reduced
101
Closed
2

Sector Composition

Rank Sector Weight
1 Healthcare 20.46%
2 Technology 16.47%
3 Financials 11.36%
4 Industrials 9.11%
5 Communication Services 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFA icon
201
iShares MSCI EAFE ETF
EFA
$78B
-16,096
Closed -$1.06M

Similar funds

Roberts, Glore & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Roberts, Glore & Co held 201 positions worth $299M, up 3.9% from $288M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 4.5%. Roberts, Glore & Co opened 7 new positions and exited 2, leaving the 201-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Roberts, Glore & Co's largest Q1 2023 buy was Global Payments: 4,544 shares worth $478K.
  • Roberts, Glore & Co added most to Charles River Laboratories in Q1 2023, an estimated $585K increase.
  • Roberts, Glore & Co's biggest Q1 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $933K.
  • Roberts, Glore & Co fully exited iShares MSCI EAFE ETF in Q1 2023, selling an estimated $1.06M.
  • Roberts, Glore & Co's ten largest holdings make up 36% of its $299M portfolio in Q1 2023.
  • Roberts, Glore & Co opened 7 new positions and closed 2 in Q1 2023.
  • Roberts, Glore & Co's portfolio value rose 3.9% quarter-over-quarter to $299M.

Based on Roberts, Glore & Co's 13F filing for Q1 2023, filed 8 May 2023.